Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 101–150 of 18393
appointed (i) Gregory S. Patton, the Company’s Executive Vice President and Chief Financial Officer, to serve as Chief Executive Officer of the Company and as a member of the Board
On June 18, 2026, Heartbeam, Inc. (the “Company”) and Mr. Eno mutually agreed to his departure as the Company’s Chief Executive Officer, as a member of the Company’s Board of Directors (the “Board”), and as the Company’s principal executive officer, effective as of June 30, 2026
On June 24, 2026, Sarah Romano notified the Board of Directors of her resignation as Chief Financial Officer of the Company, effective July 22, 2026, or such later date as may be mutually agreed upon by the Company and Ms. Romano.
Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.
The Board appointed Richard Fang, Ph.D., 60, as the Company's Interim Chief Executive Officer, effective as of the Separation Date.
On June 17, 2026, Patrick NJ Schnegelsberg notified Picard Medical, Inc. (the "Company") of his decision to step down as Chief Executive Officer and as a member of the Board of Directors of the Company (the "Board"), effective June 18, 2026
On June 16, 2026, Ben M. Palmer, Director, President, and Chief Executive Officer of RPC, Inc. (the “Company”), notified the Company of his decision to retire as Director, President, and Chief Executive Officer, effective on the earlier of a successor being named or December 31, 2026, after which he will remain in an advisory capacity to support the transition of leadership.
On June 23, 2026, the Company announced the appointment of David Denton as Executive Vice President and Chief Financial Officer (“CFO”), effective as of August 16, 2026
On June 23, 2026, the Company also announced that, as of the Effective Date, Matthew Friend will cease serving as Executive Vice President and CFO and begin serving as an advisor to the Chief Executive Officer of the Company and remain a full-time non-executive employee of the Company in that role through his separation from the Company on September 4, 2026
the Board of Directors of the Company has appointed Clinton Roeder as Executive Vice President and Chief Financial Officer of the Company, effective as of June 22, 2026.
Team, Inc. (the “Company”) announced that Nelson Haight will depart from his role as Executive Vice President and Chief Financial Officer of the Company, effective as of June 22, 2026.
Mr. Young will succeed Joseph M. Busky, who previously announced his plans to retire
The Board of Directors of QuidelOrtho Corporation (the “Company”) has appointed Micah Young to serve as the Company’s Chief Financial Officer and principal financial officer, effective as of July 6, 2026
stepping down as the Company’s Chief Executive Officer and Chairman of the Board, effective June 17, 2026
the Board appointed Mr. Weizhi (Eric) Shao to serve as Chief Executive Officer of the Company, effective as of the Effective Date
effective July 1, 2026, Zachary D. Hornby will cease his role as President and Chief Executive Officer, and as a member of the board of directors of Boundless Bio.
Will Mudd, who currently serves as Senior Vice President, Finance of the Company, has been appointed Senior Vice President and Chief Financial Officer of the Company, also effective as of July 1, 2026.
Best Buy Co., Inc. (the “Company” or “registrant”) announced that Matt Bilunas, the Company’s Senior Executive Vice President, Chief Financial Officer and Enterprise Strategy, will depart the Company effective July 31, 2026.
Howard Wilson, who has served as the CFO of the Company since 2016, has ceased serving as CFO on the Appointment Date, as previously disclosed.
On June 22, 2026, PagerDuty, Inc. (the “Company”) announced the appointment of Eric Prengel as the Company’s Chief Financial Officer (“CFO”), effective June 22, 2026 (the “Appointment Date”).
On June 22, 2026, TaskUs, Inc. (the “Company”) announced the appointment of Rishabh Khemka as Chief Financial Officer , effective as of June 19, 2026.
The Board of Directors appointed Peter G. Eames, age 50, currently serving as Vice President of Advanced Technology, as President and Chief Executive Officer effective at that time.
the Board appointed Joseph H. Jordan, age 53, to serve as the Company’s next Chief Executive Officer and as a director on the Board, effective at 12:00 a.m. ET on October 1, 2026
Russell J. Weiner informed Domino’s Pizza, Inc. (the “Company”) that he will retire as the Company’s Chief Executive Officer effective at 11:59 p.m. ET on September 30, 2026.
the Company notified Brian Ragsdale that his contract with the Company would not be renewed and would terminate effective August 11, 2026.
On June 18, 2026, Kenneth Yee appointed Bradley E. Scher as Chairman of the Board and director of the Company, as well as President and Chief Executive Officer.
on June 4, 2026, Dr. Amy T. Clemens was appointed to serve as Chief Financial Officer of the Company.
On June 22, 2026, Johnson Outdoors Inc. (the “ Company ”) announced that it has appointed Asad Rahman as Vice President and Chief Financial Officer of the Company effective as of June 30, 2026.
Mr. Johnson will step down from those roles effective as of June 30, 2026.
appointed Axel André as Chief Financial Officer of the Company, effective July 27, 2026
Effective June 17, 2026, the board of directors (the “Board”) of the Company appointed John Fraser, the Company’s current Chairman of the Board, to serve as its Interim Chief Executive Officer while a search of internal and external candidates is conducted.
On June 17, 2026, Michael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. (the "Company").
On June 15, 2026, Axel André, Executive Vice President and Chief Financial Officer of Reinsurance Group of America, Incorporated (the “Company”), informed the Company of his resignation from the Company effective July 17, 2026.
Effective June 22, 2026, Laura Cockill, Executive Vice President, Chief Strategy Officer, will assume the role of Executive Vice President and Chief Financial Officer.
Effective June 22, 2026, t he Board of Directors (the “Board”) of Rayonier Advanced Materials Inc. (“RYAM” or the “Company”) appointed Daniel M. Krawczyk as Chief Executive Officer and President of the Company.
Effective June 15, 2026, Blair Aiken is elected by the Board of Directors to serve as President and interim CEO of Panamera Holdings Corporation (collectively, the “Company”).
On June 18, 2026, the board of directors (the “Board”) of the Company appointed Robert Weinstein to the positions of Chief Accounting Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective immediately.
On June 18, 2026, Petros Pharmaceuticals, Inc. (the “Company”) and Mitchell Arnold, who served as the Company’s Vice President of Finance, Principal Accounting Officer and Principal Financial Officer, mutually agreed to the separation of Mr. Arnold from such roles, effective as of June 18, 2026
Vishwas Setia was separated as the Chief Financial Officer of MapLight Therapeutics, Inc. (the “Company”), effective immediately, following a review of a human resources violation.
the board of directors of the Company appointed Jonathan Gillis, the Company’s Chief Administrative and Accounting Officer, as the Company’s interim Chief Financial Officer and interim principal financial officer, effective June 18, 2026.
On June 15, 2026, Mondelēz International, Inc. (the “Company”) announced the appointment of Amit Banati as Executive Vice President and Chief Financial Officer, effective July 1, 2026 (the “Start Date”).
until Shimon Steinmetz commences his employment as the Company's Chief Financial Officer on or around July 27, 2026, as previously disclosed.
On June 16, 2026, the Company’s Board of Directors appointed Peter Hansen-Chambers as its new Chief Financial Officer
Effective June 18, 2026, Eric Greenhaus resigned as Chief Financial Officer, principal financial officer and principal accounting officer of the Company.
Effective June 18, 2026, Robert Rivas Collins resigned as Chief Executive Officer and principal executive officer of the Company.
Effective June 18, 2026, the Board appointed Chinh Chu, the current President of the Company, as the principal executive officer of the Company.
approved the election of Matthew Domeyer to the position of Chief Financial Officer of the Company, to be effective on July 20, 2026
On June 17, 2026, the Company’s Board of Directors appointed Richard Kaiser as the Company’s interim Chief Executive Officer.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
On June 17, 2026, the Company’s Board of Directors received resignation letters from Mr. Steven Gagnon and Mr. John LaViolette as BioForce Nanosciences Holdings, Inc.’s Co-Chief Executive Officers (CEOs), and from Sasha Shapiro the Company’s Vice-President.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.